Related Experiment Video

Updated: May 18, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines

Claudia M J Lucero1, Oscar A Vega, Mariana M Osorio

  • 1Millennium Institute on Immunology and Immunotherapy, University of Chile, Santiago, Chile.

Journal of Cellular Physiology
|September 6, 2012
PubMed

Insights

Runx2 protein levels are cell cycle-regulated in most osteosarcoma cells, but constitutive expression in some lines. Forced Runx2 expression suppresses growth, highlighting the need to balance its levels in bone tumors.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Biology

Background:

  • Runx2 (Runt-related transcription factor 2) is crucial for bone formation but can suppress osteoblast proliferation.
  • Dysregulated Runx2 is implicated in osteosarcoma progression and poor chemotherapy response.
  • Runx2's growth-suppressive function is normally controlled by protein destabilization and cell cycle regulation.

Purpose of the Study:

  • To investigate the cell cycle regulation of Runx2 protein levels in human osteosarcoma cell lines.
  • To determine the effect of Runx2 overexpression on osteosarcoma cell proliferation.

Main Methods:

  • Analysis of cell cycle progression and Runx2 protein levels in six human osteosarcoma cell lines (SaOS, MG63, U2OS, HOS, G292, 143B).
  • Forced expression of Runx2 in these cell lines to assess its impact on growth.

Main Results:

  • Osteosarcoma cell lines exhibit varying growth rates and cell cycle lengths.
  • Runx2 protein levels were cell cycle-regulated in U2OS, HOS, G292, and 143B cells, but constitutively expressed in SaOS and MG63 cells.
  • Forced Runx2 expression inhibited proliferation across all tested osteosarcoma cell lines.

Conclusions:

  • Osteosarcoma cells display differential regulation of Runx2 protein levels during the cell cycle.
  • Excessive Runx2 accumulation triggers anti-proliferative pathways in osteosarcoma.
  • Effective therapeutic strategies for osteosarcoma may require precise control of Runx2 levels to balance oncogenic functions and tumor growth.

More Related Videos

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells06:13

Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells

Published on: January 16, 2026

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...